BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.

被引：0
|
作者：
Rodriguez, A. A.
Makris, A.
Harrison, M. K.
Ostler, P. J.
Froehlich, A.
Pavlick, A.
Wong, H.
Tsimelzon, A.
Sexton, K.
Hilsenbeck, S. G.
Lewis, M. T.
Rimawi, M.
Osborne, C. K.
Chang, J. C.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Mt Vernon Hosp, Middlesex, England
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358S / 358S
页数：1
相关论文
共 50 条
  • [1] A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer.
    Rodriguez, A. A.
    Rimawi, M.
    Wu, M-F
    Dave, B.
    Wong, H.
    Landis, M.
    Cairo, M.
    Pavlick, A.
    Froehlich, A.
    Chamness, G.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Osborne, C. K.
    Chang, J.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 509S - 509S
  • [2] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [3] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [4] Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer
    Danzinger, Sabine
    Tan, Yen Yen
    Rudas, Margaretha
    Kastner, Marie-Theres
    Weingartshofer, Sigrid
    Muhr, Daniela
    Singer, Christian F.
    [J]. CANCER INVESTIGATION, 2018, 36 (07) : 378 - 388
  • [5] BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
    Jacot, William
    Lopez-Crapez, Evelyne
    Mollevi, Caroline
    Boissiere-Michot, Florence
    Simony-Lafontaine, Joelle
    Ho-Pun-Cheung, Alexandre
    Chartron, Elodie
    Theillet, Charles
    Lemoine, Antoinette
    Saffroy, Raphael
    Lamy, Pierre-Jean
    Guiu, Severine
    [J]. CANCERS, 2020, 12 (04)
  • [6] Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
    Xu, Y.
    Diao, L.
    Chen, Y.
    Liu, Y.
    Wang, C.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Deng, D.
    Narod, S. A.
    Xie, Y.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (06) : 1498 - 1505
  • [7] Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.
    Muendlein, Axel
    Rhode, Bettina
    Gasser, Klaus
    Kinz, Elena
    Drexel, Heinz
    Hofmann, Wera
    Schindler, Verena
    Kapoor, Rita
    Decker, Thomas
    Lang, Alois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Arisa Morizono
    Masahiko Tanabe
    Masako Ikemura
    Takeshi Sasaki
    Tetsuo Ushiku
    Yasuyuki Seto
    [J]. Journal of Human Genetics, 2021, 66 : 785 - 793
  • [9] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Morizono, Arisa
    Tanabe, Masahiko
    Ikemura, Masako
    Sasaki, Takeshi
    Ushiku, Tetsuo
    Seto, Yasuyuki
    [J]. JOURNAL OF HUMAN GENETICS, 2021, 66 (08) : 785 - 793
  • [10] A gene expression signature of MEK pathway activation to predict survival in triple-negative breast cancer.
    Balko, Justin M.
    Sanders, Melinda
    Gabriela Kuba, Maria
    Pinto, Joseph A.
    Doimi, Franco F.
    Leonidas Gomez, Henry
    Arteaga, Carlos L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345